Villanueva, Esmeregildo E.
HRN: 13-56-50 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/21/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/21/2025
12/27/2025
IV
4.5 Grams
Q 6 Hrs
Dm Foot
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes